Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemofarm Banja Luka is a leading pharmaceutical manufacturer based in Bosnia and Herzegovina and a key subsidiary of the Hemofarm Group, which is part of the international STADA Group. The company operates a state-of-the-art production facility in Banja Luka that specializes in the manufacture of generic prescription and over-the-counter medicines. Its extensive portfolio covers critical therapeutic areas such as cardiovascular health, central nervous system disorders, and infectious diseases. Adhering to strict EU Good Manufacturing Practice (GMP) standards, the company serves as a vital export hub, supplying medicines to markets across Southeast Europe and beyond. Hemofarm Banja Luka is recognized as one of the most significant industrial players in the region, focusing on providing high-quality, affordable healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemofarm Banja Luka.